Kooman & Associates’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $301K | Buy |
7,834
+2,142
| +38% | +$82.3K | 0.1% | 41 |
|
|
2025
Q1 | $221K | Buy |
+5,692
| New | +$221K | 0.08% | 45 |
|
|
2024
Q4 | – | Sell |
-6,229
| Closed | -$255K | – | 49 |
|
|
2024
Q3 | $255K | Hold |
6,229
| – | – | 0.09% | 40 |
|
|
2024
Q2 | $240K | Hold |
6,229
| – | – | 0.1% | 37 |
|
|
2024
Q1 | $267K | Sell |
6,229
-40
| -0.6% | -$1.72K | 0.11% | 33 |
|
|
2023
Q4 | $232K | Buy |
6,269
+40
| +0.6% | +$1.48K | 0.1% | 36 |
|
|
2023
Q3 | $226K | Hold |
6,229
| – | – | 0.11% | 35 |
|
|
2023
Q2 | $222K | Sell |
6,229
-47
| -0.7% | -$1.68K | 0.11% | 37 |
|
|
2023
Q1 | $223K | Buy |
6,276
+582
| +10% | +$20.7K | 0.12% | 36 |
|
|
2022
Q4 | $200K | Buy |
+5,694
| New | +$200K | 0.2% | 39 |
|